The Community Pharmacy Contractual Framework for 2019/20 to 2023/24: supporting delivery for the NHS Long Term Plan – Department of Health and Social Care

The new contractual arrangements will come into force from 1 October 2019 and will help to deliver the ambitions set out in the NHS Long Term Plan.  It presents a 5-year deal setting out how community pharmacy will support delivery of

A short summary of The Community Pharmacy Contractual Framework for 2019/20 to 2023/24: supporting delivery for the NHS Long Term Plan – NHS England and NHS Improvement

The document is a summary of changes to the community pharmacy contractual framework for 2019/20 to 2023/24, which was published jointly by the Department of Health and Social Care, the Pharmaceutical Services Negotiating Committee (PSNC).

Community pharmacy contractual framework: Letter from Ed Waller – NHS England and NHS Improvement

Letter from from Ed Waller to the Directors of Commissioning, Regional Heads of Primary Care, Heads of Primary Care, CCG Clinical Leads and Accountable Officers about the community pharmacy contractual framework.

PSNC Briefing 024/19: NHS Long Term Plan Implementation Framework – Pharmaceutical Services Negotiating Committee

This briefing summarises the elements of the NHS long term plan implementation framework that are of most relevance to community pharmacy contractors and local pharmaceutical committees.

Drugs policy: medicinal cannabis: Sixteenth Report of Session 2017–19: Report, together with formal minutes relating to the report – House of Commons Health and Social Care Committee

Report from the House of Commons Health and Social Care Committee that finds despite the rescheduling of medicinal cannabis, very few prescriptions have been issued. One of the many reasons for this is because of the gaps in the evidence

Equality and Health Inequalities: Full Analysis: Items which should not routinely be prescribed in primary care: an update and a consultation on further guidance for CCGs – NHS England

This is the equality impact assessment for the consultation ‘Items which should not routinely be prescribed in primary care – a consultation on guidance for CCGs’ which ran between 21 July and 21 October 2017.  

Report of findings: Items which should not routinely be prescribed in primary care: an update and a consultation on further guidance for CCGs

‘Items which should not routinely be prescribed in primary care – a consultation on guidance for CCGs’  ran between 21 July and 21 October 2017 – these are the results to this consultation.

Brexit letter to suppliers of medicines and medical products – Department of Health and Social Care

A letter to suppliers giving an update on ensuring a continued supply of medicines and medical products if the UK leaves the EU with no deal. The letter sets out: how the government plans to ensure a continued supply of

A new ambition for crosssector collaboration with the life sciences industry to support NHS sustainability and transformation – NHS Confederation

The NHS must be an active participant with industry in delivering the shared objective of outstanding patient outcomes. In part that is because it is a monopoly purchaser but also because the NHS should be where innovative products are developed

The Human Medicines (Amendment etc.) (EU Exit) (No. 2) and the Medical Devices (Amendment etc.) (EU Exit) (No. 2) Regulations 2019 – Department of Health and Social Care

These Regulations (which come into force immediately before exit day) are made to correct drafting defects and omissions in the Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775) and the Medical Devices (Amendment etc.) (EU Exit) Regulations 2019

Regulation 28: Report to prevent future deaths: Terence Bradfield – Courts and Tribunal Judiciary

Date of report: 11 March 2019 Ref: 2019-0086 Deceased name: Terence Bradfield Coroners name: Deborah Archer Coroners Area: Plymouth Torbay and South Devon Category: Hospital Death (Clinical Procedures and medical management) related deaths This report is being sent to: University

Regulation 28: Report to prevent future deaths: Megan Jones – Courts and Tribunal Judiciary

Date of report: 17 April 2019 Deceased name: Megan Jones Coroners name: Caroline Sumeray Coroners Area: Isle of Wight Category: Hospital Death (Clinical Procedures and medical management) related deaths This report is being sent to: Hampshire and Isle of Wight

Guidance for Local Pharmaceutical Committees (LPCs) – How to help contractors get involved with Primary Care Networks – NHS England

This briefing is intended to enable Local Pharmaceutical Committees (LPCs) to help contractors to get involved with Primary Care Networks.

Medicines in health and adult social care: Learning from risks and sharing good practice for better outcomes – Care Quality Commission

Care Quality Commission report that describes lessons for better medicines optimisation across health and social care providers and the positive impact of involving pharmacy professionals in health and social care settings.  

Clinical Commissioning Policy Statement: Pazopanib for inoperable and metastatic malignant granular cell tumour (all ages) [170117P] – NHS England

This policy statement is to confirm that pazopanib is not recommended as a treatment option for inoperable and metastatic malignant granular cell tumours (all ages).  

Pazopanib for inoperable and metastatic malignant granular cell tumour (all ages): Clinical Panel Report – NHS England

Clinical Panel report on Pazopanib for inoperable and metastatic malignant granular cell tumour (all ages). This policy statement is to confirm that pazopanib is not recommended as a treatment option for inoperable and metastatic malignant granular cell tumours (all ages).